Hepatocellular carcinoma after ablation: The imaging follow-up scheme

被引:14
作者
Liu, Lin-Na [1 ]
Xu, Hui-Xiong [1 ]
Zhang, Yi-Feng [1 ]
Xu, Jun-Mei [1 ]
机构
[1] Tongji Univ, Peoples Hosp 10, Dept Med Ultrasound, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China
关键词
Hepatocellular carcinoma; Radiofrequency ablation; Ethanol ablation; Contrast-enhanced ultrasound; Follow-up; Treatment response; Computed tomography; CONTRAST-ENHANCED ULTRASOUND; PERCUTANEOUS THERMAL ABLATION; FOCAL LIVER-LESIONS; RADIOFREQUENCY ABLATION; INTRAHEPATIC CHOLANGIOCARCINOMA; DIAGNOSTIC PERFORMANCE; DIFFERENTIAL-DIAGNOSIS; PROGNOSTIC-FACTORS; SONOGRAPHY; MICROWAVE;
D O I
10.3748/wjg.v19.i6.797
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Percutaneous ablation using thermal or chemical methods has been widely used in the treatment of hepatocellular carcinoma (HCC). Nowadays, contrast-enhanced imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and contrast-enhanced ultrasound (CEUS) are widely used to evaluate local treatment response after ablation therapies. CEUS is gaining increasing attention due to its characteristics including real-time scanning, easy performance, lack of radiation, wide availability, and lack of allergy reactions. Several studies have documented that CEUS is comparable to CT or MRI in evaluating local treatment efficacy within 1 mo of treatment. However, little information is available regarding the role of CEUS in the follow-up assessment after first successful ablation treatment. Zheng et al found that in comparison with contrast-enhanced computed tomography (CECT), the sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy of CEUS in detecting local tumor progression (LTP) were 67.5%, 97.4%, 81.8%, 94.4% and 92.3%, respectively, and were 77.7%, 92.0%, 92.4%, 76.7% and 84.0%, respectively for the detection of new intrahepatic recurrence. They concluded that the sensitivity of CEUS in detecting LTP and new intrahepatic recurrence after ablation is relatively low in comparison with CECT, and CEUS cannot replace CECT in the follow-up assessment after percutaneous ablation for HCC. These results are meaningful and instructive, and indicated that in the follow-up period, the use of CEUS alone is not sufficient. In this commentary, we discuss the discordance between CT and CEUS, as well as the underlying mechanisms involved. We propose the combined use of CT and CEUS which will reduce false positive and negative results in both modalities. We also discuss future issues, such as an evidence-based ideal imaging follow-up scheme, and a cost-effectiveness analysis of this imaging follow-up scheme. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:797 / 801
页数:5
相关论文
共 51 条
[1]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[2]   Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT [J].
Chen, L-D ;
Xu, H-X ;
Xie, X-Y ;
Lu, M-D ;
Xu, Z-F ;
Liu, G-J ;
Liang, J-Y ;
Lin, M-X .
BRITISH JOURNAL OF RADIOLOGY, 2008, 81 (971) :881-889
[3]   Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound [J].
Chen, Li-Da ;
Xu, Hui-Xiong ;
Xie, Xiao-Yan ;
Xie, Xiao-Hua ;
Xu, Zuo-Feng ;
Liu, Guang-Jian ;
Wang, Zhu ;
Lin, Man-Xia ;
Lu, Ming-De .
EUROPEAN RADIOLOGY, 2010, 20 (03) :743-753
[4]   The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation [J].
Chen, M. H. ;
Yang, W. ;
Yan, K. ;
Dai, Y. ;
Wu, W. ;
Fan, Z. H. ;
Callstrom, M. R. ;
Charboneau, J. W. .
CLINICAL RADIOLOGY, 2007, 62 (08) :752-760
[5]   The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy [J].
Chen, Min-Hua ;
Wu, Wei ;
Yang, Wei ;
Dai, Ying ;
Gao, Wen ;
Yin, Shan-Shan ;
Yan, Kun .
JOURNAL OF ULTRASOUND IN MEDICINE, 2007, 26 (08) :1055-1063
[6]   Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2012 A WFUMB-EFSUMB Initiative in Cooperation With Representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS [J].
Claudon, M. ;
Dietrich, C. F. ;
Choi, B. I. ;
Cosgrove, D. O. ;
Kudo, M. ;
Nolsoe, C. P. ;
Piscaglia, F. ;
Wilson, S. R. ;
Barr, R. G. ;
Chammas, M. C. ;
Chaubal, N. G. ;
Chen, M. -H. ;
Clevert, D. A. ;
Correas, J. M. ;
Ding, H. ;
Forsberg, F. ;
Fowlkes, J. B. ;
Gibson, R. N. ;
Goldberg, B. B. ;
Lassau, N. ;
Leen, E. L. S. ;
Mattrey, R. F. ;
Moriyasu, F. ;
Solbiati, L. ;
Weskott, H. -P. ;
Xu, H. -X. .
ULTRASCHALL IN DER MEDIZIN, 2013, 34 (01) :11-29
[7]   Efficacy of Contrast-Enhanced US versus CT or MRI for the Therapeutic Control of Percutaneous Radio-frequency Ablation in the Case of Hepatic Malignancies [J].
Frieser, M. ;
Kiesel, J. ;
Lindner, A. ;
Bernatik, T. ;
Haensler, J. M. ;
Janka, R. ;
Hahn, E. G. ;
Strobel, D. .
ULTRASCHALL IN DER MEDIZIN, 2011, 32 (02) :148-153
[8]   Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma [J].
Gallotti, A. ;
D'Onofrio, M. ;
Ruzzenente, A. ;
Martone, E. ;
De Robertis, R. ;
Guglielmi, A. ;
Mucelli, R. Pozzi .
RADIOLOGIA MEDICA, 2009, 114 (07) :1094-1105
[9]   Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion [J].
Ippolito, Davide ;
Bonaffini, Pietro Andrea ;
Capraro, Cristina ;
Leni, Davide ;
Corso, Rocco ;
Sironi, Sandro .
ABDOMINAL IMAGING, 2013, 38 (03) :502-510
[10]   Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound [J].
Kim, Tae Kyoung ;
Lee, Kyoung Ho ;
Khalili, Korosh ;
Jang, Hyun-Jung .
ABDOMINAL IMAGING, 2011, 36 (03) :244-263